相关实验视频

Updated: Jun 21, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

在患有NAXE缺乏症的患者中,对高剂量尼亚治疗的暂时反应

Fatema Al-Amrani¹, Khalid Al-Thihli², Eiman Al-Ajmi³

¹Pediatric Neurology Unit, Department of Child Health Sultan Qaboos University Hospital, Sultan Qaboos University Muscat Sultanate of Oman.

|July 8, 2024

概括

尼雅治疗在早期发病的渐进性脑病变 (PEBEL-1和PEBEL-2) 中通过稳定症状显示出有前途. 然而,一个患有PEBEL-1的患者尽管服用了高剂量的氨酸,但经历了致命的结局,这表明治疗反应变化.

科学领域:

线粒体疾病线粒体疾病
神经退行性疾病的神经退行性疾病
儿科神经学儿科神经学

背景情况:

NAXE脑病变 (PEBEL-1) 和NAXD脑病变 (PEBEL-2) 是严重的早期发生的线粒体疾病.
这些疾病会导致神经系统逐渐衰退,通常导致儿童早期死亡.
尼阿被假设通过支持NAD合成来帮助治疗.

研究的目的:

报告PEBEL-1患者对氨酸治疗的临床反应.
审查关于对PEBEL-1和PEBEL-2治疗尼亚的现有文献.
描述使用COX2抑制剂来控制素诱导的疹.

主要方法:

一个PEBEL-1患者用尼亚治疗的病例报告.
对接受尼亚的PEBEL-1和PEBEL-2患者进行系统的文献搜索.
对临床数据和治疗反应的审查.
描述COX2抑制剂用于疹的非标签性使用.

主要成果:

七名先前报告的PEBEL-1/PEBEL-2患者表现出尼阿辛的症状稳定.
报告的PEBEL-1患者最初稳定,但最终尽管服用了最大的尼亚剂量,但结果不利.
在这种特殊情况下,氨酸治疗未能阻止疾病的进展.

结论:

尼亚补充剂在一些PEBEL-1/PEBEL-2患者中显示出积极的结果.
这份报告强调了一例PEBEL-1病例,尽管高剂量氨酸治疗,但结果是致命的.
在PEBEL-1/PEBEL-2中对尼亚的治疗反应可能是可变的.

关键词:

这是一种COX2抑制剂.在NAXD脑病变中,大脑病变是指NAXD脑病变.纳克斯脑病变 - - 脑病变在PEBEL-2中,您可以使用PEBEL-2.早期发病的渐进性脑病变与大脑和/或白脑病变-1 (PEBEL-1).尼雅是什么意思尼雅是什么意思维生素B3 维生素B3 是一种维生素.

更多相关视频

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

相关概念视频

Transducer Mechanism: Nuclear Receptors

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

Drugs Acting on Autonomic Ganglia: Stimulants

Drugs Acting on Autonomic Ganglia: Stimulants

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

Antianginal Drugs: Nitrates and β-Blockers

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....

Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview

Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview

Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...

Nitric Oxide Signaling Pathway

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...